A Phase 1 Study of Multiple Escalating Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus Type 2 Interventions: Drug: PF-07081532; Other: Placebo; Drug: Clopidogrel Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Clopidogrel | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Pfizer | Plavix | Research | Study